Wordt geladen...
Minireview: Challenges and Opportunities in Development of PPAR Agonists
The clinical impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ. However, substantial differences exist in the therapeutic and side-effect pro...
Bewaard in:
| Gepubliceerd in: | Mol Endocrinol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Endocrine Society
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414793/ https://ncbi.nlm.nih.gov/pubmed/25148456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2013-1427 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|